NCT00343850View on ClinicalTrials.gov

Once Daily Versus Conventional Dosing of Asacol in the Maintenance of Quiescent Ulcerative Colitis

PHASE3CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

March 31, 2007

Study Completion Date

March 31, 2007

Conditions
Ulcerative Colitis
Interventions
DRUG

Asacol (mesalamine)

Trial Locations (1)

60637

The University of Chicago, Chicago

All Listed Sponsors
collaborator

Procter and Gamble

INDUSTRY

lead

University of Chicago

OTHER

NCT00343850 - Once Daily Versus Conventional Dosing of Asacol in the Maintenance of Quiescent Ulcerative Colitis | Biotech Hunter | Biotech Hunter